Interact to see
Advertisement
Advertisement
ISPVX vs VSCIX
ISPVX vs VSCIX Comparison
Open Charts ISPVX vs VSCIX
ISPVX vs VSCIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
ISPVX vs. VSCIX commentary
Aug 12, 2026
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ISPVX is a Buy and VSCIX is a Buy.
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 183B vs. ISPVX (386M). VSCIX pays higher dividends than ISPVX: VSCIX (1.23) vs ISPVX (0.34). ISPVX was incepted earlier than VSCIX: ISPVX (12 years) vs VSCIX (29 years). ISPVX (0.95) is less costly to investors than VSCIX (0.03). ISPVX is a more actively managed with annual turnover of: 22.00 vs. VSCIX (17.00). ISPVX has a lower initial minimum investment than VSCIX: ISPVX (0) vs VSCIX (5000000). ISPVX annual gain was more profitable for investors over the last year : 32.83 vs. VSCIX (27.44). VSCIX return over 5 years is better than : 38.20 vs. ISPVX (4.01).
| ISPVX | VSCIX | ISPVX / VSCIX | |
| Total Expense Ratio | 0.77 | 0.03 | 2,567% |
| Annual Report Gross Expense Ratio | 0.95 | 0.03 | 3,167% |
| Fund Existence | 12 years | 29 years | - |
| Gain YTD | 22.004 | 18.473 | 119% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 5000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 386M | 183B | 0% |
| Annual Yield % from dividends | 0.34 | 1.23 | 28% |
| Returns for 1 year | 32.83 | 27.44 | 120% |
| Returns for 3 years | 60.32 | 52.73 | 114% |
| Returns for 5 years | 4.01 | 38.20 | 11% |
| Returns for 10 years | 49.68 | 160.35 | 31% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RYBOX | 75.44 | 0.77 | +1.03% |
| Rydex Biotechnology A | |||
| WSMNX | 28.57 | 0.03 | +0.11% |
| William Blair Small-Mid Cap Growth N | |||
| MCLRX | 18.40 | 0.01 | +0.05% |
| BlackRock Advantage Large Cap Core Inv C | |||
| PABGX | 208.29 | -0.51 | -0.24% |
| T. Rowe Price Blue Chip Growth Advisor | |||
| HSCCX | 3.24 | -0.02 | -0.61% |
| Carillon Eagle Small Cap Growth C | |||